Akèy › Kansè poumon › Georgia › Savannah
Etid klinik pou Kansè poumon nan Savannah, GA
10 etid pou Kansè poumon ap chèche patisipan nan sit nan ak bò kote Savannah (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
- Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi lwen
- South Carolina Cancer Specialists PC, Hilton Head Island · 22 mi lwen
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Low Country Cancer Care, Savannah
- Memorial Health University Medical Center, Savannah
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Ap rekriteFaz 3
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Ap rekriteFaz 3
- Lewis Cancer and Research Pavilion ( Site 0063), Savannah
- Saint Joseph's Candler Health System ( Site 4010), Bluffton · 18 mi lwen
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Summit Cancer Care PC, Savannah
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
- Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi lwen
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
- Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi lwen
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2/3
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
- Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi lwen
- South Carolina Cancer Specialists PC, Hilton Head Island · 22 mi lwen
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Ap rekriteEtid obsèvasyon
- Memorial Health University Medical Center, Savannah
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
- Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi lwen
- ak 1 plis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Savannah
Etid Kansè poumon nan lòt vil
- Houston, TX78 etid
- Boston, MA62 etid
- New York City, NY60 etid
- Los Angeles, CA45 etid
- Washington, DC41 etid
- Arlington, VA41 etid
- Chicago, IL41 etid
- Nashville, TN40 etid
- Baltimore, MD40 etid
- St. Louis, MO39 etid
- Columbus, OH37 etid
- Philadelphia, PA36 etid
Lòt etid nan Savannah
- Kansè nan tete11 etid
- Kansè Poumon ki pa ti selil10 etid
- Kansè (tout kalite)6 etid
- Twoub depresif majè6 etid
- Dyabèt Tip 26 etid
- BPCO5 etid
- Melanom5 etid
- Kansè ovè4 etid
- Kansè kolorektal4 etid
- Kansè Endomèt3 etid
- Limfòm Burkitt3 etid
- Dematit atopik (Ekzema)3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.